Youcare Pharmaceutical Group Co Ltd Class A 688658
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥17.28
- Day Range
- ¥18.43–20.60
- 52-Week Range
- ¥11.99–23.79
- Bid/Ask
- ¥20.35 / ¥20.36
- Market Cap
- ¥9.16 Bil
- Volume/Avg
- 10.7 Mil / 3.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 162.74
- Price/Sales
- 2.34
- Dividend Yield (Trailing)
- 0.98%
- Dividend Yield (Forward)
- 0.98%
- Total Yield
- 0.98%
Company Profile
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Value
- Total Number of Employees
- 3,179
- Website
- http://www.youcareyk.com
Comparables
Valuation
|
Metric
|
688658
|
603896
|
300142
|
|---|---|---|---|
Price/Earnings (Normalized) | 162.74 | 20.69 | 78.48 |
Price/Book Value | 2.56 | 2.25 | 2.49 |
Price/Sales | 2.34 | 6.33 | 6.97 |
Price/Cash Flow | 24.94 | 13.42 | 21.71 |
Price/Earnings
688658
603896
300142
Financial Strength
|
Metric
|
688658
|
603896
|
300142
|
|---|---|---|---|
Quick Ratio | 1.35 | 3.21 | 2.51 |
Current Ratio | 1.82 | 3.70 | 2.94 |
Interest Coverage | 6.92 | 16.62 | 24.73 |
Quick Ratio
688658
603896
300142
Profitability
|
Metric
|
688658
|
603896
|
300142
|
|---|---|---|---|
Return on Assets (Normalized) | 0.83% | 7.55% | 1.93% |
Return on Equity (Normalized) | 1.36% | 11.00% | 3.16% |
Return on Invested Capital (Normalized) | 1.16% | 7.10% | 2.01% |
Return on Assets
688658
603896
300142
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Xbhxmldx | Zpvr | $512.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Dynntkzz | Cglpjs | $117.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Vdndxddl | Vhsnyv | $111.6 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Xwbsqfdn | Zcwzrvg | $34.4 Bil | |||
| argenx SE ADR
ARGX
| Ktwbxvswy | Rzxx | $31.7 Bil | |||
| BioNTech SE ADR
BNTX
| Ycprqwdr | Wmll | $29.2 Bil | |||
| Moderna Inc
MRNA
| Mhlnsxkn | Nftr | $23.1 Bil | |||
| United Therapeutics Corp
UTHR
| Kdldsspdn | Dxwv | $15.8 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Ftbctsdw | Gpydm | $13.2 Bil | |||
| Incyte Corp
INCY
| Ncwvxnlvs | Hrllghz | $13.0 Bil |
United States